- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02274168
Utility of ICD Electrograms During Ventricular Tachycardia Ablation
December 9, 2022 updated by: Fundación Hospital de Madrid
Aid of Recording ICD Electrograms During Monomorphic Ventricular Tachycardia Ablation Procedures
With the increasing use of implantable cardioverter defibrillators (ICD) for primary prevention in patients with structural heart disease, an increasing number of patients are expected to develop their first episode of monomorphic ventricular tachycardia (VT) after an ICD is in place and the only documentation of the clinical arrhythmia will be the ICD electrogram (EG).
The absence of a 12-lead ECG in patients with an ICD and sustained monomorphic VT represents a limitation when performing treatment with radiofrequency (RF) ablation.
The analysis of ICD-EG during a RF ablation procedure is expected to provide a reference "model" of VT with clinical expression consisting of the electrical signal of the ICD during VT (which otherwise is not generally possible to obtain in ICD patients).
This will allow for a more targeted approach to the substrate of the VT with clinical expression because: 1) if VT is induced by programmed stimulation, one can tell whether it is with clinical expression or not, and 2) if VT is not induced, ventricular pacing could be performed based on the comparative analysis of morphology and activation times of ICD-EG.
These approaches will result in improved outcomes of the ablation procedure.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
260
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Alicante, Spain
- Hospital General Universitario
-
Barcelona, Spain
- Hospital del Mar
-
Barcelona, Spain
- Hospital de la Santa Creu i Sant Pau
-
Bilbao, Spain
- Hospital Universitario de Basurto
-
Burgos, Spain
- Hospital Universitario de Burgos
-
Granada, Spain
- Hospital Universitario Virgen de las Nieves
-
Las Palmas, Spain
- Hospital Universitario Insular de Gran Canaria
-
Madrid, Spain
- Hospital Universitario La Paz
-
Madrid, Spain
- Hospital Universitario Ramon Y Cajal
-
Madrid, Spain
- HM hospitales
-
Murcia, Spain
- Hospital Universitario Virgen de la Arrixaca
-
Sevilla, Spain
- Hospital Universitario Nuestra Señora de Valme
-
Toledo, Spain
- Hospital Virgen De La Salud
-
Valencia, Spain
- Hospital Clinico Universitario
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18 years or older
- Clinical indication for RF catheter ablation
- Presence of an implanted ICD
- At least 1 episode of spontaneous sustained monomorphic VT documented with ICD electrogram
- Presence of structural heart disease
- Able to obtain signed informed consent and willing to comply with study activity requirements
Exclusion Criteria:
- It is anticipated that data can not be obtained during follow-up
- Unwilling or unable to provide informed consent
- Women who are or may potentially be pregnant
- Patients who are participating in another clinical trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Conventional RF catheter ablation
Conventional RF ablation will be performed without using ICD-EG information
|
RF catheter ablation will be performed as usually done by each center.
No ICD EGMs will be obtained and used during the ablation procedure (do not place the programming head over the ICD generator).
|
Other: Investigational RF Catheter Ablation using ICD-EG information
RF Catheter Ablation will be performed using ICD-EG information
|
RF ablation procedure will be performed with the programming head over the ICD generator.
ICD EGMs will be registered every time VT is induced and during ventricular pacing.
ICD EGMs obtained during ablation procedure will be compared with the EGMs of the registered spontaneus VT and used to locate appropriate ablation sites.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percentage of patients free of VT recurrence
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction in number of VT recurrence
Time Frame: 6 months
|
6 months
|
|
Reduction in the proportion of patients free of VT recurrence
Time Frame: 6 months
|
6 months
|
|
Reduction in the proportion of patients free of recurrence in patients in whom 12-lead ECG of the spontaneous VT is not available and in those in whom hemodinamically tolerated VT is not induced
Time Frame: 6 months and total follow-up
|
6 months and total follow-up
|
|
Improvement of spatial resolution of the ICD-EG after information from local ventricular endocardial acceleration is added
Time Frame: 6 months
|
This outcome will be studied from the stored signal together with the ICD-EG on the device in the subgroup of patients with a device that allows to obtain this parameter.
In the remaining patients, signals will be obtained noninvasively with a seismocardiogram using a highly sensitive accelerometer located in the sternal midline of the xiphoid process and simultaneously synchronized with the ECG.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Jesus Almendral, MD, HM hospitales
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Yoshida K, Liu TY, Scott C, Hero A, Yokokawa M, Gupta S, Good E, Morady F, Bogun F. The value of defibrillator electrograms for recognition of clinical ventricular tachycardias and for pace mapping of post-infarction ventricular tachycardia. J Am Coll Cardiol. 2010 Sep 14;56(12):969-79. doi: 10.1016/j.jacc.2010.04.043.
- Almendral J, Marchlinski F. Is it the same or a different ventricular tachycardia?: an additional use for defibrillator electrograms. J Am Coll Cardiol. 2010 Sep 14;56(12):980-2. doi: 10.1016/j.jacc.2010.03.081. No abstract available.
- Almendral J, Atienza F, Everss E, Castilla L, Gonzalez-Torrecilla E, Ormaetxe J, Arenal A, Ortiz M, Sanroman-Junquera M, Mora-Jimenez I, Bellon JM, Rojo JL. Implantable defibrillator electrograms and origin of left ventricular impulses: an analysis of regionalization ability and visual spatial resolution. J Cardiovasc Electrophysiol. 2012 May;23(5):506-14. doi: 10.1111/j.1540-8167.2011.02233.x. Epub 2011 Dec 8.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2011
Primary Completion (Actual)
March 1, 2022
Study Completion (Actual)
March 1, 2022
Study Registration Dates
First Submitted
September 14, 2014
First Submitted That Met QC Criteria
October 22, 2014
First Posted (Estimate)
October 24, 2014
Study Record Updates
Last Update Posted (Estimate)
December 13, 2022
Last Update Submitted That Met QC Criteria
December 9, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AIDEG-VTA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sustained Monomorphic Ventricular Tachycardia
-
Hospital General Universitario Gregorio MarañonCompletedMonomorphic Ventricular TachycardiaSpain
-
Abbott Medical DevicesTerminatedMonomorphic Ventricular TachycardiaUnited States, United Kingdom, France, Australia, Italy
-
Abbott Medical DevicesWithdrawn
-
Adagio MedicalActive, not recruitingMonomorphic Ventricular TachycardiaNetherlands, Czechia, Canada, Belgium, France, Germany
-
Biotronik SE & Co. KGCompletedVentricular Tachycardia, MonomorphicAustria, Finland, Germany, Israel
-
CardioSolv Ablation TechnologiesTerminatedIschemic Monomorphic Ventricular TachycardiaUnited States
-
Adagio MedicalRecruitingSustained VTUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedArrhythmiasDenmark, United States, Italy, Brazil, Russian Federation, Canada, Serbia, United Kingdom, Romania, Ukraine, India, Sweden, Mexico, Croatia, Hungary, Poland
-
Imperial College LondonWithdrawnMyocardial Infarction | Dilated Cardiomyopathy | Monomorphic Ventricular TachycardiaUnited Kingdom
-
Rigshospitalet, DenmarkRecruitingCoronary Artery Disease | Ventricular Fibrillation | Acute Myocardial Infarction | Out-Of-Hospital Cardiac Arrest | Ventricular Tachycardia, SustainedDenmark
Clinical Trials on Conventional RF catheter ablation
-
Oxford University Hospitals NHS TrustCompletedAtrial FibrillationUnited Kingdom
-
University of California, San FranciscoCompletedAtrial Fibrillation | Atrial Fibrillation, Persistent | Atrial Fibrillation ParoxysmalUnited States
-
Abbott Medical DevicesTerminatedParoxysmal Atrial FibrillationGermany
-
Hansen MedicalTerminatedParoxysmal Atrial FibrillationUnited States, Denmark, Czechia, Spain, United Kingdom
-
Sequoia HospitalUnknownPersistent Atrial Fibrillation | Chronic Atrial FibrillationUnited States
-
Abbott Medical DevicesActive, not recruitingVentricular TachycardiaSpain, United States, France, United Kingdom, Australia, Italy, Germany, Czechia
-
Biosense Webster, Inc.Recruiting
-
Biosense Webster, Inc.Active, not recruitingAtrial FibrillationBelgium, Denmark, Austria, Lithuania
-
Bursa Postgraduate HospitalWithdrawn